Arkamin

📦 Každá objednávka je pokryta naší Zárukou opětovného odeslání — pokud vaše zásilka nedorazí do 20 pracovních dnů, přeposíláme ji.

Proč objednávat z MedsBase

Naše generické léky pocházejí od výrobců certifikovaných WHO-GMP a jsou expedovány po celém světě v diskrétním, nenápadném balení – na vnější straně balíku není uveden název léku. Platby kartou jsou směrovány prostřednictvím regulovaného procesoru (popisky na výpisu zahrnují regulovaného procesora plateb kartou – nikdy “MedsBase” nebo název léku). Přijímáme také kryptoměny a bankovní převody SEPA. Každá objednávka je zajištěna naší politikou přeposlání.

What Is Arkamin?

Arkamin is an oral 100 mcg Clonidine tablet from Torrent Pharma, supplied in 30-90 tablets. Clonidine was introduced by Boehringer Ingelheim in 1966 as Catapres. Originally synthesised as a nasal decongestant, an accidental observation of profound hypotension in a trial volunteer led to its repurposing as an antihypertensive. Modern use spans hypertension (fourth-line and hypertensive urgency), ADHD (FDA-approved in the US as Kapvay ER), opioid and nicotine withdrawal, menopausal vasomotor symptoms, Tourette syndrome, pain adjuncts (intrathecal), and anaesthetic pre-medication.

How Clonidine Works

Clonidine acts on pre-synaptic alpha-2 adrenergic receptors (and imidazoline-1 receptors) in the rostral ventrolateral medulla. The downstream effects:

• Reduced central sympathetic outflow — activation of pre-synaptic alpha-2 receptors in the rostral ventrolateral medulla suppresses descending sympathetic tone to the peripheral vasculature and heart
• Reduced plasma noradrenaline — circulating catecholamines fall 30-50% within hours; heart rate drops 5-15 bpm; BP drops 10-30 mmHg
• Imidazoline-1 receptor activity — an additional sympathetic-suppressing mechanism unique to imidazoline agonists (clonidine, moxonidine); may contribute to better metabolic tolerability than older centrally-acting drugs
• Spinal and supraspinal analgesic action — blocks pain signal relay in the dorsal horn; basis for intrathecal clonidine in chronic pain and for anaesthetic-adjunct use
• Suppression of noradrenergic withdrawal symptoms — reduces sweating, tremor, tachycardia, and hypertension during opioid, nicotine, and alcohol withdrawal
• Improved prefrontal cortical tone — proposed mechanism for ADHD benefit (enhances top-down inhibitory control)
• Central anti-thermoregulatory action — basis for menopausal hot-flush benefit

Approved and Evidence-Based Uses

• Resistant or fourth-line hypertension, hypertensive urgency (oral/sublingual), ADHD, opioid/nicotine withdrawal, menopausal flushing, pain and anaesthetic adjuncts
• Resistant hypertension (fourth/fifth-line)
• Hypertensive urgency (oral 100-200 mcg loading, then 100 mcg hourly) — not for emergency with end-organ damage
• ADHD (FDA-approved as extended-release Kapvay; standard IR forms used off-label globally)
• Opioid and nicotine withdrawal — autonomic symptom relief
• Menopausal vasomotor symptoms (hot flushes) — non-hormonal option
• Tourette syndrome and tic disorders
• Chronic pain — intrathecal clonidine for neuropathic or cancer pain
• Anaesthetic pre-medication and peri-operative shivering

Pivotal trial evidence: VA Cooperative Study on Hypertension (1967-1970) — clonidine established as effective monotherapy in the era before ACEi, ARB, and CCB classes. ALLHAT subgroup analyses — clonidine-based regimens generally reduced BP equivalently to first-line classes but with worse tolerability. Connor et al. pediatric ADHD trials — clonidine IR effective for hyperarousal and sleep disturbance in ADHD, though psychostimulants remain first-line. Gold et al. (1978) — landmark demonstration of clonidine for opiate withdrawal — abolished autonomic symptoms (sweating, piloerection, tachycardia) without cross-dependence.

Arkamin Dosage

Primary dose: Chronic hypertension: 100 mcg (0.1 mg) two or three times daily, titrating to a usual maximum of 800 mcg/day. Not a first-line antihypertensive — reserve for fourth/fifth-line after ACEi/ARB, CCB, thiazide, and spironolactone. Hypertensive urgency (oral): 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) — use IV agents.

Other indications: ADHD (children and adolescents): 50-100 mcg at bedtime initially, titrating to 100-400 mcg/day in divided doses. Extended-release formulations (Kapvay) are preferred in the US. Opioid withdrawal (autonomic symptom relief): 100-300 mcg three or four times daily, tapering as withdrawal resolves. Menopausal hot flushes: 50-75 mcg twice daily. Tourette syndrome: 25-100 mcg twice or three times daily. Smoking cessation: 100-300 mcg/day (oral or transdermal). Anaesthetic pre-medication: 200-400 mcg orally 60 minutes pre-op.

Administration: take with or without food; evening doses are larger than daytime to shift sedation into sleep. Do not miss doses (rebound risk).

Monitoring schedule:

• Baseline: supine and standing BP (document postural drop), heart rate, ECG (bradycardia screen), medication list (check for interacting agents).
• Week 1-2: repeat BP (supine and standing), heart rate, symptom review. Adjust dose up or down based on BP and tolerability.
• Week 4-6: assess target BP; symptom burden; ask specifically about missed doses.
• Ongoing: annual BP and cardiac review; never run out of supply (rebound HTN risk).
• Stop or dose-reduce on: severe bradycardia, syncope, second or third-degree AV block, major depression, troublesome sedation unimproved at 4-8 weeks.

Discontinuation: CRITICAL — never stop clonidine abruptly. Rebound hypertension with surge of sympathetic activity can occur within 18-36 hours at doses >300 mcg/day. Taper over 2-4 weeks; if a beta-blocker is co-prescribed, stop the beta-blocker first and clonidine later. Seek urgent medical care for severe headache, chest pain, or BP >180/110 after missed or stopped doses.

Practical Considerations for Arkamin

• Rebound hypertension on abrupt discontinuation — CRITICAL, potentially life-threatening. Missed doses or sudden stopping can cause a surge of sympathetic activity within 18-36 hours: BP rise of 30-50 mmHg, tachycardia, sweating, tremor, and rare reports of stroke, MI, and hypertensive encephalopathy. Always taper clonidine over 2-4 weeks rather than stopping abruptly. The risk is greatest at doses >300 mcg/day and in combination with beta-blockers.
• Transdermal patch (Catapres TTS, 100/200/300 mcg per day patches applied weekly) gives smoother plasma levels and mitigates rebound risk — useful for patients with adherence issues.
• Sedation and dry mouth are nearly universal on initiation; usually partially abate over 2-4 weeks. Take at bedtime for the main dose to shift sedation into sleep.
• Beta-blocker co-therapy caution — if discontinuing, stop the beta-blocker first, then taper clonidine several days later; reverse order can cause especially severe rebound because the beta-blocker blocks the compensatory reflexes.

Vedlejší účinky

Common (>1%):

• Sedation, somnolence (very common, especially first 2-4 weeks)
• Dry mouth (very common)
• Dizziness, orthostatic hypotension
• Constipation
• Erectile dysfunction and reduced libido
• Depression, mood change
• Bradycardia, heart block (especially with beta-blocker or digoxin co-therapy)
• Weight gain, salt retention over months
• Skin reactions with transdermal patch (contact dermatitis 10-50%)
• Sleep disturbance, vivid dreams, nightmares

Uncommon but clinically important:

• Rebound hypertensive crisis on abrupt discontinuation — stroke, MI, hypertensive encephalopathy reported.
• Severe bradycardia and atrioventricular block, especially with beta-blocker, digoxin, or non-dihydropyridine CCB (verapamil, diltiazem) co-therapy.
• Profound sedation interfering with work or driving — dose-limiting in some patients.
• Depression or worsening of pre-existing depression.
• Sinus node dysfunction, syncope.
• Severe allergic contact dermatitis with transdermal patch — rotate sites; stop if severe.

Kontraindikace

• Known hypersensitivity to clonidine
• Severe bradyarrhythmia, sick sinus syndrome, second or third-degree AV block without pacemaker
• Severe depression (relative)
• Concurrent use of other central alpha-2 agonists (methyldopa, tizanidine) — additive hypotension and sedation
• Pregnancy: generally avoided (prefer methyldopa or labetalol); data are limited, not clearly teratogenic, but experience is much larger with alternatives
• Breastfeeding: enters breast milk significantly

Pregnancy: generally avoided as first-choice — methyldopa and labetalol have larger safety databases. Clonidine is not clearly teratogenic and is sometimes used as add-on therapy in resistant gestational hypertension.

Breastfeeding: significant transfer to breast milk — monitor the infant for sedation, bradycardia, and poor feeding; consider alternative agents.

Interakce s léčivy

• Beta-blockers — CRITICAL. Co-therapy worsens clonidine-withdrawal rebound hypertension. If both drugs are stopped together, stop the beta-blocker several days first, then taper clonidine. Beta-blockers also increase bradycardia risk when combined with clonidine.
• Digoxin, non-dihydropyridine CCBs (verapamil, diltiazem) — additive bradycardia and AV block.
• Tricyclic antidepressants and alpha-antagonists — partially antagonise clonidine’s antihypertensive effect; may require higher clonidine doses.
• CNS depressants (opioids, benzodiazepines, alcohol, gabapentinoids) — additive sedation.
• Other centrally-acting antihypertensives (methyldopa, tizanidine, moxonidine) — additive sedation and hypotension; usually not combined.
• Mirtazapine — alpha-2 antagonism reduces clonidine effect.
• Diuretika — synergistic BP-lowering; standard combination in resistant HTN.

Where Arkamin Fits in the Antihypertensive Hierarchy

Skladování

Store Arkamin below 25°C in the original blister pack. Keep out of reach of children.

Často kladené dotazy

Why is it so dangerous to miss doses of Arkamin?

Clonidine suppresses central sympathetic outflow. When clonidine levels fall abruptly, the stored sympathetic drive “rebounds” within 18-36 hours — BP surges 30-50 mmHg, heart rate rises, and the patient sweats, tremors, and develops severe headache. Case reports describe rebound stroke, myocardial infarction, and hypertensive encephalopathy. This risk is greatest at doses above 300 mcg/day and with concurrent beta-blockade. Never stop clonidine abruptly — taper over 2-4 weeks under medical supervision. Always order repeat supply 1-2 weeks before running out.

Will Arkamin make me drowsy?

Yes — sedation and daytime somnolence are the most common complaints, affecting up to half of patients in the first 2-4 weeks. It usually improves substantially by week 4-6. Strategies: shift more of the daily dose to bedtime so sedation occurs during sleep; avoid alcohol and other CNS depressants; do not drive or operate machinery until you know how Arkamin affects you. If sedation remains unacceptable after 6-8 weeks, switch to an alternative (moxonidine, methyldopa in pregnancy only, or a different antihypertensive class).

Can I take Arkamin with alcohol?

Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension and sedation of Arkamin — falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.

Can Arkamin be used for ADHD?

Yes — clonidine is FDA-approved in the United States as extended-release Kapvay for ADHD in children and adolescents, and is used off-label (as immediate-release) internationally. It is not first-line (psychostimulants — methylphenidate, amphetamines — give larger mean effect sizes on core ADHD symptoms), but clonidine has a specific niche in hyperarousal, sleep onset, tics, and stimulant-side-effect management. Typical paediatric dose: 50-100 mcg at bedtime initially, titrating to 100-400 mcg/day in divided doses under specialist supervision.

Co když vynechám dávku?

Take the missed dose as soon as you remember, even if it is close to the next scheduled dose — clonidine’s rebound-hypertension risk means that missed doses must be replaced promptly. If you realise within 6 hours, take the missed dose and continue as normal. If more than 12 hours have passed and rebound symptoms (severe headache, palpitations, sweating) are emerging, take the dose and seek urgent medical review. Never let your supply run out — order repeat prescriptions 1-2 weeks before the current stock is exhausted.

Can I stop Arkamin if my BP is under control?

Not abruptly. Rebound hypertension within 18-36 hours of stopping clonidine can precipitate stroke, MI, or hypertensive encephalopathy. Always taper over 2-4 weeks under medical supervision. If you are on a beta-blocker, stop the beta-blocker first, then taper clonidine several days later.

Can I take Arkamin in pregnancy?

Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine — Arkamin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.

Where can I buy Arkamin online?

You can buy Arkamin (100 mcg clonidine, 30-90 tablets) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

• Aldactone — Spironolactone 25/50/100 mg (PATHWAY-2 4th-line)
• Alphadopa — Methyldopa 250 mg (pregnancy-safe HTN)
• Hytrin — Terazosin 1/2/5 mg (AbbVie)
• Minipress XL — Prazosin ER 2.5/5 mg (Pfizer)
• Ramcor — Ramipril 2.5/5/10 mg (ACEi)
• Telma H — Telmisartan + HCTZ combination
• Browse all High Blood Pressure Medications

Související alternativy

Další produkty v Chronická onemocnění které zákazníci také prohlížejí:

• Robinax
• Affexor XR
• Xyzal
• Duolin Inhaler
• Noltrexate

Další možnosti v léčbě vysokého krevního tlaku

Řazeno podle nedávného objemu objednávek na MedsBase — co si ostatní zákazníci v této kategorii vybírají.

Telmaheal

US$9.00 – US$36.00Zakres cen: US$9.00 do US$36.00

Losar

US$6.53 – US$29.25Zakres cen: US$6.53 do US$29.25

Amlode

US$5.50 – US$24.00Zakres cen: US$5.50 do US$24.00

Minoxytop

US$22.00 – US$170.00Zakres cen: US$22.00 do US$170.00